ITMIG2021 – Program

Scientific Program

Program of

11th virtual ITMIG 2021 Annual Meeting

TIME (EST)

FRIDAY, OCTOBER 15, 2021

08:30 – 11:30

COMMITTEE MEETINGS – all participants are welcome!

13:00 – 14:00

Plenary session

ITMIG Prospective Database – a worldwide project for thymic tumors

Nicolas Girard (15 min)

Live Q&A

Advances in thoracic surgery for thymic tumors

Jens Ruckert (15 min)

Live Q&A

Advances in systemic therapy for thymic tumors

Patrick Loehrer (15 min)

Live Q&A

TIME (EST)

SATURDAY, OCTOBER 16, 2021

08:30 – 08:40

Opening of a conference

08:40 – 09:30

Session 1: The small mediastinal lesion and early-stage thymic tumor

Chairs/Moderators: Paul Van Schil, Charles Simone

Imaging the small mediastinal lesion

Edith Marom (15 min)

The small mediastinal lesion – management options

Joshua Sonett (15 min)

Thymomectomy or complete thymectomy of early-stage thymic tumor: Thymomectomy is sufficient

Wentao Fang (10 min)

Thymomectomy or complete thymectomy of early-stage thymic tumor: Complete thymectomy is more effective

Marlies Keijzers (10 min)

09:30 – 10:00

Oral Abstract Session 1

10:00 – 10:30

Live Q&A

10:30 – 11:00

Break

11:00 – 12:00

Session 2: Thymic tumors and clinical correlates (part 1):
Neurological comorbidities

Chair/Moderator: Giuseppe Cardillo

Paraneoplastic syndromes associated with thymoma beyond myasthenia gravis

Berthold Schalke (15 min)

Multidisciplinary approach to pre- and post-thymectomy care of thymoma patients

Anna Kostera- Pruszczyk (15 min)

Clinical and laboratory features heralding the appearance of thymomas

Maria Isabel Leite (15 min)

Clinical workup of the asymptomatic patient with suspected thymoma

Alper Toker (15 min)

12:00 – 12:30

Oral Abstract Session 2

12:30 – 13:00

Live Q&A

13:00 – 13:30

Break

13:30 – 14:30

Session 3: Thymic tumors and clinical correlates (part 2):
Thymic pathology and SARS-CoV-2 infection
TETs in children

Chair/Moderator: Sukhmani Padda

Thymic pathology in COVID-19 patients

Amira Marouf (15 min)

COVID-19 in patients with myasthenia gravis

Richard Nowak (15 min)

Effect of SARS-CoV-2 epidemic on the management of thymic tumor patients

Alan Kirk (15 min)

Thymic tumors in children

Daniel Orbach (15 min)

14:30 – 15:00

Live Q&A

TIME (EST)

SUNDAY, OCTOBER 17, 2021

08:30 – 09:50

Session 4: Metastatic pleural disease in the course of TETs – multidisciplinary approach

Chair/Moderator: Andreas Rimner

Cases presentation – what strategy do you propose? (I-st voting)

Conrad Falkson (15 min)

Imaging of metastatic pleural dissemination

Jeanne Ackman (15 min)

Surgical options for treatment of metastatic pleural disease

Meinoshin Okumura (15 min)

Radiation strategy and technics for metastatic pleural disease

Annemarie Shepherd (15 min)

When to observe and when to start systemic therapy? Systemic treatment options for metastatic pleural disease

Gregory Riely (15 min)

Cases presentation – re-evaluation. What strategy do you propose now? (II-nd voting) 

Conrad Falkson (5 min)

09:50 – 10:25

Live Q&A

10:25 – 11:00

Break

11:00 – 12:00

Session 5: Updates in mediastinal tumors classifications:
TNM 8th Ed.,
WHO 2021 histological classification
Mediastinal compartments/CT

Chair/Moderator: Enrico Ruffini

TNM 8th. Ed. staging of TETs – UPDATE – Pathologist’s perspective

Thierry Molina (10 min)

TNM 8th. Ed. staging of TETs – UPDATE – Surgeon’s perspective

Dong Kwan Kim (10 min)

TNM 8th. Ed. staging of TETs – UPDATE – Medical oncologist’s perspective

Nicolas Girard (10 min)

TNM 8th. Ed. staging of TETs – UPDATE – Radiation oncologist’s perspective

Abigail Berman (10 min)

WHO 2021 histological classification for mediastinal tumors

Alexander Marx (10 min)

ITMIG classification (CT-based) of mediastinal compartments

Brett Carter (10 min)

12:00 – 12:30

Oral Abstract Session 3

12:30 – 13:00

Live Q&A

13:00 – 13:20

Break

13:20 – 14:00

Session 6: Thymic carcinomas vs. lung carcinomas

Chair/Moderator: James Huang

Thymic carcinomas vs. lung carcinomas – Radiologist’s perspective

Chad Strange (10 min)

Thymic carcinomas vs. lung carcinomas – Pathologist’s perspective

Malgorzata Szolkowska (10 min)

Thymic carcinomas vs. lung carcinomas – Surgeon’s perspective

Frank Detterbeck (10 min)

Thymic carcinomas vs. lung carcinomas – Medical oncologist’s perspective

Arun Rajan (10 min)

14:00 – 14:20

Live Q&A

14:20 – 14:50

Live Tumor Board: borderline (thymic/lung) case presentation 

Presenter: Marcin Zielinski

Experts panel: Anja Roden, Mylene Truong, Dirk Van Raemdonck, Ritsuko Komaki, Heather Wakelee

14:50 – 15:00

Closing of a conference